UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 216

Sortiert nach

De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor

Journal of the American Chemical Society, 2019-12, Vol.141 (49), p.19193-19197

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1506-1516

2016

Link zum Volltext

Verfügbarkeit prüfen

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Japanese journal of clinical oncology, 2019-08, Vol.49 (8), p.762-765

2019

Link zum Volltext

Verfügbarkeit prüfen

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics

Experimental cell research, 2023-03, Vol.424 (1), p.113503-113503, Article 113503

2023

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors

Cancer Immunology, Immunotherapy, 2021, Vol.70 (1), p.101-106

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Japanese journal of clinical oncology, 2020-12, Vol.50 (12), p.1447-1453

2020

Link zum Volltext

Verfügbarkeit prüfen

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

Cancer science, 2020-10, Vol.111 (10), p.3739-3746

2020

Link zum Volltext

Verfügbarkeit prüfen

Practical Advanced Care Planning for Patients with Thoracic Cancer

Haigan, 2023/06/20, Vol.63(3), pp.147-152

2023

Link zum Volltext

Verfügbarkeit prüfen

Subpopulation of small‐cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Cancer science, 2013-01, Vol.104 (1), p.78-84

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive Factors for the Efficacy of Immune Checkpoint Inhibitors Against Lung Cancer

Haigan, 2022/10/20, Vol.62(5), pp.355-362

2022

Link zum Volltext

Verfügbarkeit prüfen

Erythema as a Visual Surrogate Marker of Glucagonoma

Internal Medicine, 2018/08/01, Vol.57(15), pp.2283-2284

2018

Link zum Volltext

Verfügbarkeit prüfen

Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors

Journal of cancer research and clinical oncology, 2021-12, Vol.147 (12), p.3749-3755

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

Acta medica Okayama, 2023-02, Vol.77 (1), p.65-70

2023

Link zum Volltext

Verfügbarkeit prüfen

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

PloS one, 2009-11, Vol.4 (11), p.e7835

2009

Link zum Volltext

Verfügbarkeit prüfen

Dropped Head Syndrome Following Mantle Radiation Therapy

Internal Medicine, 2016, Vol.55(4), pp.421-422

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer

Japanese journal of clinical oncology, 2021-02, Vol.51 (2), p.279

2021

Link zum Volltext

Verfügbarkeit prüfen

Time to Bone Union after Hybrid Closed-Wedge High Tibial Osteotomy

Acta medica Okayama, 2019-12, Vol.73 (6), p.511-516

2019

Link zum Volltext

Verfügbarkeit prüfen

Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404

Japanese journal of clinical oncology, 2021-08, Vol.51 (8), p.1269-1276

2021

Link zum Volltext

Verfügbarkeit prüfen

Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019

Thoracic cancer, 2023-06, Vol.14 (16), p.1538-1539

2023

Link zum Volltext

Verfügbarkeit prüfen

Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?

Cancers, 2020-07, Vol.12 (7), p.1995

2020

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of TBXAS1 in an iron‐induced malignant mesothelioma model

Cancer science, 2015-10, Vol.106 (10), p.1296-1302

2015

Link zum Volltext

Verfügbarkeit prüfen

Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs

Acta medica Okayama, 2019-12, Vol.73 (6), p.537-542

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit

Palliative medicine reports, 2023-09, Vol.4 (1), p.278-287

2023

Link zum Volltext

Verfügbarkeit prüfen

Gynecomastia as a Paraneoplastic Symptom of Choriocarcinoma

Internal Medicine, 2016/09/15, Vol.55(18), pp.2739-2740

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(111)
Oncology
(72)
Humans
(71)
Lung Cancer
(44)
Female
(42)
Male
(37)
Chemotherapy
(33)
Lung Neoplasms - Drug Therapy
(26)
Patients
(24)
Respiratory System
(22)
Aged
(21)
Medicine
(21)
Middle Aged
(20)
Cancer Research
(18)
Lung Neoplasms - Genetics
(17)
Medicine & Public Health
(17)
Animals
(15)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Immune Checkpoint Inhibitor
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor

Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

The complexity of EGFR exon 19 deletion and L858R mutant cells as assessed by proteomics, transcriptomics, and metabolomics

Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status

Practical Advanced Care Planning for Patients with Thoracic Cancer

Subpopulation of small‐cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

Predictive Factors for the Efficacy of Immune Checkpoint Inhibitors Against Lung Cancer

Erythema as a Visual Surrogate Marker of Glucagonoma

Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results

Dropped Head Syndrome Following Mantle Radiation Therapy

Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer

Time to Bone Union after Hybrid Closed-Wedge High Tibial Osteotomy

Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404

Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019

Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?

Downregulation of TBXAS1 in an iron‐induced malignant mesothelioma model

Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs

Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit

Gynecomastia as a Paraneoplastic Symptom of Choriocarcinoma

The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study

Suchergebnisse filtern